openPR Logo
Press release

Global Peptide Based Gastrointestinal Disorders Therapeutics Market Set to Expand at XX% CAGR, Projected to Reach USD XX Billion by 2032 due to Rising Global Prevalence of Gastrointestinal Disorders

07-04-2024 02:19 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Dataintelo

/ PR Agency: Dataintelo
Dataintelo

Dataintelo

Dataintelo reports that the global peptide-based gastrointestinal disorders therapeutics market size, valued at USD XX billion in 2023, is expected to reach a total market size of USD XX billion by 2032. Projected to expand at a CAGR of XX% during the years 2024-2032, market growth can be attributed to the increasing prevalence of various gastrointestinal disorders around the world.

As gastrointestinal disorders such as irritable bowel syndrome, inflammatory bowel disease, and gastroesophageal reflux disease become more common, the demand for more effective therapeutics has significantly increased. This surge in demand has played a significant role in propelling the market for peptide-based gastrointestinal disorder therapeutics.

This report by Dataintelo emphasizes that the high prevalence of these disorders globally necessitates the development and availability of effective treatments, shining light on the role and importance of peptide-based treatments in the therapeutics market

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐š ๐Ÿ๐ซ๐ž๐ž ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ @ https://dataintelo.com/request-sample/371836

๐“๐ก๐ข๐ฌ ๐ข๐ฌ ๐จ๐ง๐ž ๐จ๐Ÿ ๐ญ๐ก๐ž ๐ฆ๐จ๐ฌ๐ญ ๐๐ž๐ญ๐š๐ข๐ฅ๐ž๐ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐š๐ง๐ ๐œ๐จ๐ฏ๐ž๐ซ ๐ญ๐ก๐ž ๐Ÿ๐จ๐ฅ๐ฅ๐จ๐ฐ๐ข๐ง๐  ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ๐ฌ:

The Peptide Based Gastrointestinal Disorders Therapeutics market has been segmented on the basis of๐“๐ฒ๐ฉ๐ž
โ— Teduglutide
โ— Linaclotide
โ— Others

๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง
โ— Short Bowel Syndrome
โ— Chronic Constipation
โ— Irritable Bowel Syndrome
โ— Others

๐Œ๐จ๐๐ž ๐จ๐Ÿ ๐€๐๐ฆ๐ข๐ง๐ข๐ฌ๐ญ๐ซ๐š๐ญ๐ข๐จ๐ง
โ— Oral
โ— Parenteral
โ— Mucosal
โ— Others

๐ƒ๐ข๐ฌ๐ญ๐ซ๐ข๐›๐ฎ๐ญ๐ข๐จ๐ง ๐‚๐ก๐š๐ง๐ง๐ž๐ฅ
โ— Hospital Pharmacies
โ— Retail Pharmacies
โ— Online Pharmacies
โ— Others

๐‘๐ž๐ ๐ข๐จ๐ง
โ— Asia Pacific
โ— North America
โ— Latin America
โ— Europe
โ— Middle East & Africa

๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ
โ— AbbVie Inc
โ— Accredo Health Group, Inc
โ— ๐€๐ฌ๐ญ๐ž๐ฅ๐ฅ๐š๐ฌ ๐๐ก๐š๐ซ๐ฆ๐š ๐ˆ๐ง๐œ
โ— Cipher Pharmaceuticals Inc
โ— ๐ˆ๐ซ๐จ๐ง๐ฐ๐จ๐จ๐
โ— Synergy Pharma
โ— Takeda Pharmaceutical Company Limited

The global market landscape of Peptide Based Gastrointestinal Disorders Therapeutics can be dissected into several segments. The first segment revolves around the types of peptide-based therapeutics, such as Teduglutide, Linaclotide, and a miscellany of others. Each type of peptide therapeutic is designed to target different GI disorders in their own unique way. The second segment is based on the therapeutic applications, namely, Short Bowel Syndrome, Chronic Constipation, Irritable Bowel Syndrome, amongst others. The usage and efficiency of a peptide-based therapeutic entirely depend on the nature and severity of the disorder. Furthermore, the way the therapeutic is administered also forms a significant market segment. Consumers are given the option to take the medicine orally, parenterally, or mucosally based on their preference and convenience.

On a regional basis, the Peptide Based Gastrointestinal Disorders Therapeutics market is broadly categorized into North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Each region offers its unique market dynamics and opportunities. For instance, North America, being home to some of the key players such as AbbVie Inc. and Accredo Health Group, Inc., is anticipated to hold a major chunk of the market share. On the other hand, Asia Pacific, with its rapidly growing population and improving healthcare infrastructure, offers enormous untapped potential. The distribution of these therapeutics is also a significant aspect of the market and is leveraged through channels such as Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Amongst these, online pharmacies have witnessed robust growth in recent years due to the shift towards digitization and increased user convenience

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐š ๐Ÿ๐ซ๐ž๐ž ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ @ https://dataintelo.com/request-sample/371836

Market Drivers:

1. Rising Prevalence of Gastrointestinal Disorders: The increasing number of people suffering from various gastrointestinal disorders such as gastroesophageal reflux disease (GERD), peptic ulcers, irritable bowel syndrome (IBS), Crohn's disease, among others, is a significant driver of the peptide-based gastrointestinal disorders therapeutics market.

2. Advancements in Peptide Therapeutics: The advancements in peptide therapeutics, including the development of long-acting peptide drugs and the emergence of peptide conjugates, can also drive the market.

3. Increased Investment in R&D: The increase in research & development activities and funding in the pharmaceutical sector for the development of new drugs to treat gastrointestinal disorders is driving the demand for peptide-based gastrointestinal disorders therapeutics.

4. Increasing awareness about health and diseases: With an increasingly health-conscious population and better access to information, awareness about gastrointestinal disorders and their treatment methods is increasing, which is consequently driving the market.

Opportunities:

1. Product Innovation: The development of new peptide-based drugs to treat gastrointestinal disorders offers considerable opportunities for market growth.

2. Emerging markets: Countries in regions such as Asia-Pacific and Latin America, where the incidence of gastrointestinal disorders is increasing and healthcare infrastructures are improving, provide an excellent opportunity for the peptide-based gastrointestinal disorders therapeutics market to expand.

3. Personalized medicines: The opportunity to develop personalized peptide-based therapeutics based on the patient's genetic makeup and disease profile can be a significant opportunity for market players.

4. Strategic Collaborations: Collaborations between pharmaceutical companies for the development and distribution of peptide-based gastrointestinal disorder therapeutics can provide significant opportunities for market growth.

5. Aging Population: As the population ages, the prevalence of gastrointestinal disorders is expected to rise, providing a substantial market opportunity

๐˜๐จ๐ฎ ๐œ๐š๐ง ๐๐ข๐ซ๐ž๐œ๐ญ๐ฅ๐ฒ ๐›๐ฎ๐ฒ ๐ญ๐ก๐ข๐ฌ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐Ÿ๐ซ๐จ๐ฆ: https://dataintelo.com/checkout/371836

This report should be purchased by business executives, strategists, every participant who relies on business growth, and stakeholders in various industries who are interested in leveraging actionable insights from data to make informed business decisions. Market researchers, market specialists, research and development departments, business development teams, digital marketers, and trend forecasting teams would also benefit greatly from this report.

Dataintelo is a credible and renowned market intelligence company that offers comprehensive market research reports. Here are some good things about Dataintelo:

1. Customer-Centric: They offer 24/5 research support to their customers, ensuring their issues are promptly addressed and resolved.

2. Methodological Approach: Their strong methodology secures high-level data integrity and helps clients in critical decision making.

3. Wide Coverage: Dataintelo provides market analysis reports from various industries, showing you the larger picture and opening doors to numerous opportunities for business growth.

4. Highly Updated: They provide the most recent market trends and constantly update their reports to maintain relevance in the rapidly changing environment.

5. Proficient Team: Their adept team of analysts, consultants, and researchers use proprietary data sources and various tools and techniques to gather information and analyse it.

6. Customized Reports: They provide customized reports tailored to the specific needs of their clients. This helps businesses to get insights which align with their unique requirements.

7. Excellent Presentation: Their reports are well-formatted, easy-to-understand, and come with in-depth qualitative and quantitative analysis.

Overall, Dataintelo can be a reliable partner for businesses to gain insightful market reports for strategic planning and growth

Contact Us :
Dataintelo
Name - Alex Mathews
Phone No.: +1 909 414 1393
Email - sales@dataintelo.com
Website - https://dataintelo.com
Address - 500 East E Street, Ontario, CA 91764, United States.

๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐œ๐š๐ง ๐›๐ž ๐œ๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐ž๐ ๐š๐ฌ ๐ฉ๐ž๐ซ ๐ฒ๐จ๐ฎ๐ซ ๐ง๐ž๐ž๐.

๐„๐ฆ๐š๐ข๐ฅ ๐ฎ๐ฌ ๐จ๐ง - ๐ฌ๐š๐ฅ๐ž๐ฌ@๐๐š๐ญ๐š๐ข๐ง๐ญ๐ž๐ฅ๐จ.๐œ๐จ๐ฆ

๐€๐›๐จ๐ฎ๐ญ ๐ƒ๐š๐ญ๐š๐ข๐ง๐ญ๐ž๐ฅ๐จ:

๐ƒ๐š๐ญ๐š๐ข๐ง๐ญ๐ž๐ฅ๐จ boasts extensive experience in creating tailored Market research reports across diverse industry verticals. With in-depth Market analysis, creative business strategies for new entrants, and insights into the current Market scenario, our reports undergo intensive primary and secondary research, interviews, and consumer surveys.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Peptide Based Gastrointestinal Disorders Therapeutics Market Set to Expand at XX% CAGR, Projected to Reach USD XX Billion by 2032 due to Rising Global Prevalence of Gastrointestinal Disorders here

News-ID: 3566224 • Views: โ€ฆ

More Releases from Dataintelo

Carbon Carbon Composite Brake Disc Market Projected to Grow at a Steady CAGR of XX%, Segmented by Type, Manufacturing Process, Application, and More, Reveals Dataintelo Report
Carbon Carbon Composite Brake Disc Market Projected to Grow at a Steady CAGR of โ€ฆ
Dataintelo has recently unveiled a comprehensive analysis on the Carbon Carbon Composite Brake Disc Market in its latest report. The research, which is segmented by Type (2D C/C composite, 2.5D C/C composite, 3D C/C composite), by Manufacturing Process (Blow Moulding, Injection Moulding) and by Application (Motorsport, Aerospace, Heavy Vehicles), among other factors, anticipates the market to grow at a significant CAGR of XX% during the forecast period. The report considersโ€ฆ
AR Optical Waveguide Module Market to Expand at a Significant CAGR, Revealed in Dataintelo's Latest Research Report Covering In-Depth Analysis of Leading Players and Key Sectors
AR Optical Waveguide Module Market to Expand at a Significant CAGR, Revealed in โ€ฆ
Dataintelo has recently published a comprehensive study on the AR Optical Waveguide Module Market, revealing a forecast annual growth rate (CAGR) of XX%. The report is detailed and breaks down its research by aspects such as Light Detection (Infrared, Ultraviolet, Visible Light), Waveguide Type (Planar Waveguide, Channel Waveguide), Material Type (Polymer, LiNbO3, Glass, Silicon), Application (Telecommunication, Healthcare, Industrial, Aerospace and Defense), and Component (Input/Output Coupler, Waveguide Core, Cladding). The report segmentsโ€ฆ
6-Axis Robots Market Expected to Witness Significant Growth, Focusing on Key Players ABB Group, Yaskawa Electric Corporation, and Fanuc Corporation
6-Axis Robots Market Expected to Witness Significant Growth, Focusing on Key Pla โ€ฆ
In a newly published report from Dataintelo, it is revealed that the 6-Axis Robots Market is projected to experience a substantial growth, marking a significant CAGR in the forecast period. The comprehensive study is segmented by type, including Articulated, Cylindrical, Spherical, and Cartesian robots, and by application, encompassing Material Handling, Welding, Painting, and Assembly amongst others. Additionally, it explores various end-use industries, such as Automotive, Electrical and Electronics, Metals andโ€ฆ
XX% Growth Projected for Mesotherapy Market, Reveals Dataintelo's Detailed Study on Product Types, Applications, End-users, and Key Players
XX% Growth Projected for Mesotherapy Market, Reveals Dataintelo's Detailed Study โ€ฆ
In an insightful investigation of the Mesotherapy Market, Dataintelo unveils a comprehensive analysis of the key growth markers, restraints, and business prospects that will shape the industry dynamics in the coming years. The report is segmented by Product Type (Plant Extracts, Hormones, Enzymes, Vitamins, Others), by Application (Non-Surgical Liposuction, Body Contouring, Hair Restoration, Others), by End-user (Hospitals, Speciality Clinics, Aesthetic Centers), and by Technique (Nappage, Point by Point, Mesoperfusion, Mesolift,โ€ฆ

All 4 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M โ€ฆ
๐”๐’๐€, ๐๐ž๐ฐ ๐‰๐ž๐ซ๐ฌ๐ž๐ฒ- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USDย 22.32ย Billion by 2024. The valuation is expected to reach USDย 47.79ย Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of theโ€ฆ
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi โ€ฆ
๐”๐’๐€, ๐๐ž๐ฐ ๐‰๐ž๐ซ๐ฌ๐ž๐ฒ- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasingโ€ฆ
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi โ€ฆ
๐”๐’๐€, ๐๐ž๐ฐ ๐‰๐ž๐ซ๐ฌ๐ž๐ฒ- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. Asโ€ฆ
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh โ€ฆ
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of theโ€ฆ
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, โ€ฆ
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoringโ€ฆ
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 โ€ฆ
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about theโ€ฆ